Narayanan, Sriram
Au, Veonice Bijin
Khakpoor, Atefeh
Yan, Cheng
Ahl, Patricia J.
Kaliaperumal, Nivashini
Lee, Bernett
Xiang, Wen Wei
Wang, Juling
Lee, Chris
Tay, Amy
Lim, Seng Gee
Connolly, John E.
Funding for this research was provided by:
National Medical Research Council (NMRC/TCR/014-NUHS/2015)
Article History
Received: 6 January 2021
Accepted: 19 March 2021
First Online: 2 April 2021
Competing interests
: Seng Gee Lim: Advisory Board: Gilead Sciences, Merck Sharpe and Dohme, Abbvie, Abbott. Speakers Bureau: Gilead Sciences, Abbott, Merck Sharpe and Dohme, Roche. Educational/research funding: Abbott, Merck Sharpe and Dohme, Gilead Sciences. Wen Wei Xiang was an employee of Tessa Therapeutics Pvt Ltd, IMCB John Connolly is a consultant for Merck, Bit Bio, Hummingbird, Geneception. The remainder of the authors have no conflict of interest.